Interleukin-17A biomarker as a predictor for detection of early axial spondyloarthritis changes in patients with psoriasis.

Dena Mamdouh SeragMohamed A El TablNaglaa AfifiMahmoud S Abdallah Sally M El Hefnawy Shimaa A Hassanein

Published in: International journal of rheumatic diseases (2020)

Our study can imply that IL-17A is a valuable, useful and low-cost biomarker in detecting early axial SpA changes in asymptomatic and nonradiographic axial SpA (nr-axial SpA) psoriatic patients that helps early management and prevent progressive axial involvement and disabilities.

Keyphrases

low cost
end stage renal disease
ankylosing spondylitis
disease activity
ejection fraction
multiple sclerosis
rheumatoid arthritis
chronic kidney disease
prognostic factors
peritoneal dialysis
loop mediated isothermal amplification
label free